chronic myeloid leukemia
| 4 min read
Billion-dollar partnerships, Phase 1 wins, AI regulatory tools, and more led the news this week.
| 5 min read
Advances in allosteric inhibitors may offer a new standard of care that balances potent disease control with better tolerability and convenience.
Page 1 of 1 - 2 Total Items
